Vimarsana
Biggest News Aggregation in the World

Page 16 - Inducement Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inducement Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inducement Plan Today - Breaking & Trending Today

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced the grant of an inducement award to the Company’s recently appointed Chief Commercial Officer, Nicole Sweeny. In connection with Ms. Sweeny’s appointment, the compensation committee of KalVista’s bo...

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Aug 2, 2023--

Applied Optoelectronics Announces Equity Grants To Employees Under Inducement Plan - Vimarsana News

Applied Optoelectronics Announces Equity Grants To Employees Under Inducement Plan

Sugar Land, TexasApplied Optoelectronics, Inc. , a leading provider of fiber-optic access network products for the cable broadband, internet datacenter, telecom and fiber-to-the-home markets, today...

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on July 31,...

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Seres Therapeutics, Inc. , a leading microbiome therapeutics company, today announced that on July 13, 2023, the Compensation and Talent Committee of Seres’ board of directors granted inducement...